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Abstract.  Chromosome 6-encoded dystrophin-related- 
protein (DRP) shows significant structural  similarities 
to dystrophin at the carboxyl terminus,  though the two 
proteins are encoded on different chromosomes.  Both 
DRP and dystrophin are expressed in muscle and brain 
and show some similarity in their subcellular localiza- 
tion. For example, in skeletal muscle both are expressed 
at neuromuscular and myotendinous junctions.  How- 
ever,  while dystrophin is absent or severely reduced in 
Duchenne/Becker muscular dystrophy, DRP continues 
to be expressed.  Within the brain,  dystrophin is en- 
riched at the postsynaptic regions of specific subsets of 
neurons,  while the distribution of DRP is yet to be 
described. In this  study we demonstrate a distinct 
though highly specific pattern of distribution of DRP 
in the brain.  DRP is enriched in the choroid plexus, 
pia mater,  intracerebral  vasculature,  and ependymal 
lining.  Within the parenchyma proper,  DRP is located 
at the inner plasma face of astrocytic foot processes at 
the abluminal aspect of the blood-brain barrier.  The 
distribution of DRP is conserved across a large evolu- 
tionary distance, from mammals to elasmobranchs, sug- 
gesting that DRP may play a role in the maintenance 
of regional specializations in the brain. 
YSTROPHIN is a large cytoskeletal protein belonging 
to  the  superfamily  of spectrin-like  proteins.  It  is 
closely associated with the inner face of the plasma- 
lemma in muscle and postsynaptic  region of neurons in the 
brain (Hoffman et al.,  1987; Koenig et al.,  1988; Arahata 
et al.,  1988;  Bonilla  et al.,  1988;  Watldns  et al.,  1988; 
Zubrzycka-Gaarn et al., 1988; Miike et al.,  1989; Lidov et 
al.,  1990).  The  role of dystrophin  in muscle or neurons 
remains  unclear,  however  mutations in the gene encoding 
dystrophin result in Duchenne/Becker Muscular Dystrophy 
(D/BMD),  a  disease characterized  by progressive muscle 
wasting, cognitive impairment, and death by the third decade 
of life in humans (Duchenne,  1868; Engel,  1986; Hoffman 
and Kunkel,  1989). 
The spectrin superfamily includes a class of proteins shar- 
ing limited structural similarity and organizational  motifs in- 
cluding an actin-binding  amino terminus and a 'rod' like cen- 
tral domain,  predicted to be composed of triple o~-helical 
repeat motifs (Davison and Critchley,  1988; Koenig et al., 
1988; Byers et al.,  1989).  While the carboxyl terminus  of 
dystrophin  bears  no homology to either  the  spectrins  or 
o~-actinins, it shares considerable homology with chromo- 
some 6 encoded transcript of the DMDL gene (Love et al., 
1989).  The protein product of this  autosomal transcript, 
dystrophin-related  protein  (DRP)  1 was  identified  by  ex- 
1. Abbreviation used in this paper:  DRP, dystrophin-related protein. 
pressing  the cloned transcript  as a  recombinant bacterial 
protein and generating  antibodies against the purified fusion 
protein  (Khurana  et al.,  1990).  DRP and dystrophin  are 
similar in size and present at relatively  low abundance in 
normal skeletal muscle (Hoffman et al.,  1987; Khurana  et 
al.,  1990).  However, DRP is more widely distributed than 
dystrophin, being detected in brain, blood vessels,  nerves, 
kidney, spleen, liver, testis, stomach, and muscle. Addition- 
ally,  the expression of DRP is unaltered  in age matched 
D/BMD skeletal muscle, in which dystrophin is either not 
detectable  or  severely  reduced  (Hoffman  et  al.,  1988; 
Khurana et al.,  1990). 
The  subcellular distribution  of DRP in skeletal muscle 
has recently been elucidated using  immunohistochemistry 
(Khurana  et al.,  1991; Man et al.,  1991; Ohlendieck et al., 
1991; Takemitsu et al.,  1991; Cartaud et al.,  1992). DRP is 
detected in intramuscular  nerves, blood vessels, and found 
to be enriched at the neuromuscular and myotendinous junc- 
tional areas of the adult dystrophic myofiber (Khurana et al., 
1991).  Using  antibodies  of varying  sensitivity  and  spec- 
ificity, other investigators have detected DRP at some but not 
all these sites  (Man et al.,  1991; Ohiendieck et al.,  1991; 
Takemitsu  et al.,  1991). Minimal  sarcolemmal labeling  of 
dystrophic muscle has also been noted when the sensitivity 
of DRP immunolabeling  is optimized (Khurana et al., 1991; 
Man et al.,  1991; Tanaka et al.,  1991; Voit et al.,  1991). 
However, during  muscle regeneration  intense and extended 
sarcolemmal immunolabeling  is seen to completely encircle 
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found during embryonic and perinatal development than in 
adult dystrophic muscle. Developmental studies suggest that 
DRP may play a  role similar to that of dystrophin during 
certain  developmental  stages  in  the  mdx  mouse  muscle 
(Khurana et al.,  1991; Takemitsu et al.,  1991). 
Whereas recent studies surveying the distribution of dys- 
trophin and DRP have found some similarity in their distri- 
bution in myofibres (Byers et  al.,  1991; Khurana et al., 
1991), the distribution of D RP in the brain is as yet unknown. 
However,  anomalous immunolabeling of the cerebral vas- 
culature and pial surfaces of the mdx brain using some dys- 
trophin antisera has been reported and provides hints about 
the localization of DRP in the brain (Ishiura et al.,  1990; 
Yoshioka et al., 1992), in much the same way that such cross 
reactivity did  in  skeletal  muscle  (Fardeau  et  al.,  1990; 
Samitt and Bonilla, 1990).  To address basic questions of the 
physiological role of DRP it is important to determine the 
subcellular distribution of DRP in the brain. We have there- 
fore used a combined approach of  immunoblotting, immuno- 
histochemistry, immunoelectron microscopy, and tissue cul- 
ture to define the distribution of DRP in the brain of mdx 
mice. 
Materials and Methods 
Antibody Specificity 
eDNA clones encoding the carboxyl termini of dystrophin (clone dll en- 
compassing nucleotide position 9,786-11,555  of the dystrophin sequence, 
Koenig et al., 1988) and DRP (nucleotide position 690-1,353, Love et al., 
1989: homologous to 10,457-11,518  of the dystrophin sequence, Koenig et 
al., 1988) were expressed as bacterial fusion peptides and purified as previ- 
ously described (Koenig and Kunkel, 1990; Khurana et al., 1990).  To deter- 
mine the  specificity of DRP  antibodies on immunoblotting,  equivalent 
amounts of purified fusion proteins were electrophoresed alongside each 
other  and  electro-transferred to  nitrocellulose.  The  immunoblots were 
processed using affinity purified antibodies to the carboxyl terminus of DRP 
according to previously described methods (Hoffman et al., 1987; Khurana 
et al.,  1990).  (Note: for sake of brevity in this manuscript, we will refer 
to the dystrophin and DRP fusion peptides described above, as dl l  fusion 
or DYS-pep and DRP fusion or DRP-pep, respectively). 
Peptide Competition 
An excess ('~1 mg) of either DRP peptide (DRP pep- encoding the carboxyl 
terminus of DRP) or dystrophin peptide (DYS pep- encoding the carboxyl 
terminus of dystrophin) was resuspended in 20/~1 of water. This was added 
to 100/xl of affinity purified DRP antibodies at a concentration of 1 ~tg/ml 
(final antibody concentration r~800 ng/t~l) and the mixture used for immu- 
nohistochemistry on cryostat sections of mdx brain. For comparison, 10- 
ttm-thick serial sections were incubated in parallel with (a) preimmune sera 
from the same rabbit and (b) affinity purified DRP antibodies without the 
DRP peptide at ~1 ~g/mi. Photographs were taken on Kodak Tri-X Pan film 
(Eastman Kodak Co., Rochester, NY) using the same camera settings and 
processed in parallel. 
Immunoblotting 
The methods used for immunoblotting have been previously described 
(Hoffman et al., 1987).  Briefly, 20-~m cryostat sections, aliquots of tissue, 
or pellets of mechanically harvested tissue culture cells were placed in 
preweighed 0.5- or 1.5-ml tubes and chilled on dry ice. ,'~20 mg of tissue 
were solubilized in 20 volumes of  sample buffer containing 10 % SDS, 0.1 M 
Tris, pH 8.0, 10 mM EDTA, bromopbenol blue, and 50 mM DTT.  Tissue 
lysates were made using a metallic or teflon-coated tissue homogenizer to 
thoroughly crush the sample inside the tube. The sample was boiled for 2 
rain and cooled to room temperature. Protein concentration was measured 
using a colorimetric assay by staining an aliquot of the sample with Amido 
black (Nakamura et al.,  1985).  Appropriate dilutions were loaded in each 
well to achieve uniform loading.  These aliquots were fractionated on a 
3.5-12.5 % gradient SDS-polyacrylamide get. Electrophoresis of the 1.5- 
mm-thick gel was for 3 h at 100 V or in some cases 60 V for 12 h (constant 
voltage). 
After electrophoresis, proteins were electro-transferred onto nitrocellu- 
lose filters, and the filters dried overnight. To control for uniformity of load- 
ing, the posttransfer gels were stained with Coomassie blue dye for residual 
myosin. In addition the filters were stained with Ponceau S solution (Sigma 
Chemical Co., St.  Louis, MO), which together with the transfer of pre- 
stained protein molecular weight standards served to control the efficiency 
of transfer. DRP and dystrophin antibody complexes were detected using 
alkaline phosphatase staining as  previously described (Hoffman et  al., 
1987; Khurana et al.,  1990).  Multiple filters were tested for each experi- 
ment. For quantification, the DRP band was subjected to computerized la- 
ser densitometric analysis by scanning on an LKB Ultroscan XL (LKB 
Instruments Inc., Brornma, Sweden) machine and results plotted as previ- 
ously described (Khurana et al.,  1991). 
Immunohistochemistry 
Immunohistochemistry was performed using previously described methods 
(Watkins et al., t989), mdx mice were anaesthetized and sacrificed by cervi- 
cal dislocation. Raja erinacea fish were obtained from the Marine Biologi- 
cal Laboratories (Woods Hole, MA). Fish were anaesthetized with chloral 
hydrate and sacrificed by cervical transsection. Brains were dissected out 
and various orientations of the brain placed on a marked piece of cardboard 
and plunged into isopentane cooled in liquid nitrogen and stored at -70~ 
After mounting on cold metal chucks with Tissue-Tek  O.C.T. Compound 
(Miles Laboratories Inc.,  Elkhart, IN),  5-10-/zm sections were cut and 
lifted onto gelatin or polylysine-coated  slides. Sections were fixed with cold 
methanol for 5 min and washed with PBS before being labeled with affinity 
purified DRP antibody in PBS with 10% calf serum (final concentration '~1 
~g/ml) for 1 h at room temperature. After washing in PBS, sections were 
incubated with FITC or TRITC anti-sheep or anti-rabbit antibody (Sigma 
Chemical Co.) for 1 h. Washed sections were mounted in Gelvatol (Mon- 
santo Chemical Co., St. Louis, MO) or Aqua-mount (Lerner Laboratories, 
Pittsburgh, PA). In some cases immunolabeling of serial sections was done 
with antibodies against the vascular marker, yon Willebrands Factor (Sigma 
Chemical Co.) as described above. Sections were examined using either a 
Nikon FXA (Nikon Inc.,  Melville, NY)  or Zeiss Axiophot microscope 
(Carl Zeiss, Inc., Thornwood, NY) equipped with epi-fluorescence optics. 
Immunoelectron Microscopy 
mdx mice brains were fixed by cardiac perfusion with 2 % paraformalde- 
hyde, 0.01% glutaraidehyde in PBS. Brains were removed from the cranial 
cavity and the cerebrum and cerebellum were dissected out and further fixed 
in the same buffer for a total of I h. Samples were cut into l-ram cubes and 
immersed in 2.3 M Sucrose in PBS overnight. Blocks were mounted on cut- 
ring slabs, shock frozen in liquid nitrogen, and stored under liquid nitrogen. 
70-nm sections were cut using a Reichert Ultracut microtome fitted with 
a  FC4D cryo-attachment (Reichert Scientific Instruments, Buffalo,  NY). 
Sections were mounted on 200 mesh carbon-formvar grids, labeled with an- 
tibodies to DRP and revealed with a 5-urn gold conjugate directed against 
the rabbit primary antibodies as previously described (Byers et al.,  1991). 
EM was performed with a Jeol 100-CX II (JEOL USA Inc., Peabody, MA). 
Micrographs were taken at a magnification of 29,000. 
Tissue Culture 
Anaesthetized mdx mice were sacrificed by cervical dissociation. For neu- 
ronal cultures embryonic day 18 mice were used and for glial cultures l-d- 
old mice were used. Cells were cultured by standard protocols, as described 
by Freshney (1987). Briefly, brains were removed from the cranium and the 
meninges dissected out under a ;Zeiss stereo microscope (Carl Zeiss, Inc.). 
The cerebral hemispheres were minced, trypsinized in 10 volumes of PBS 
and dissociated by forced passage through flame-polished glass pipettes. 
The supernatant pools were decanted, and the separated tissue clumps dis- 
carded. The supernatant was spun at low speed and pellet resuspended in 
culture medium. Viable cells in the cell suspension were counted using 
trypan blue exclusion. ~10  ~ cells were plated on polylysine-coated cover 
slips. Neuronal cultures were enriched by treatment with the pyrimidine 
analogue cytosine arabinoside for 4-8 d before use. Antibodies against glial 
fibrillary acidic protein (GFAP) (Sigma Chemical Co.) were used as control 
for glial contaminants. Glial cultures were stained to evaluate the purity of 
cultures which were found to be >90% positive. 
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Specificity and Sensitivity of  A~inity-Purified 
DRP Antibodies 
The domain of DRP used for expression of fusion proteins 
and antibody production is highly conserved between dystro- 
phin and DRP. We have previously demonstrated that DRP 
antibodies are specific for DRP since they recognize DRP 
but not the internally truncated, smaller dystrophin in biop- 
sies of Becker muscular dystrophy patients (Khurana et al., 
1990;  Khurana et al.,  1991). To strengthen these original 
controls we performed experiments to determine whether 
DRP antibodies could recognize extremely small amounts of 
DRP fusion peptides and distinguish DRP peptides from the 
structurally similar dystrophin fusion peptides.  DRP anti- 
bodies were used to probe an immunoblot containing in- 
creasing amounts of fusion protein representing the carboxyl 
termini of DRP and dystrophin. As demonstrated in Fig. 1, 
DRP antibody detected DRP fusion proteins at extremely 
low  concentrations  while  not  recognizing  equivalent  or 
greater amounts of fusion protein containing the correspond- 
ing carboxyl terminus of dystrophin. This observation cou- 
pled with our previous patient studies demonstrates that, on 
immunoblots, the affinity-purified DRP antibodies used in 
this study were sensitive and specific for DRP. 
Having established that the DRP antibodies were specific 
for DRP on Western blots we wished to extend these findings 
and characterize the specificity of the DRP antibodies by im- 
munottuorescence microscopy. This was especially impor- 
tant  in  light of the  possible  existence  of an  alternative, 
shorter transcript of the dystrophin locus, that is predicted 
to encode the carboxyl terminus of dystrophin alone (Bar 
et al., 1990; Rapaport et al., 1992). This short transcript and 
encoded protein are predicted to be present in mdx mouse 
brain though full length dystrophin is  absent in the mdx 
mouse (Hoffman et al., 1987). To demonstrate specificity by 
immunofluorescent microscopy, we competed the binding of 
DRP  antibodies  by  either  DRP  or  dystrophin carboxyl- 
terminal  fusion peptides.  Serial  cryostat sections of mdx 
mouse brain were incubated with DRP antibody either with 
an excess of DRP carboxyl-terminal fusion protein or with 
excess of a dystrophin carboxy-terminai fusion protein. As 
shown in  Fig.  2,  DRP  immunolabeling was  successfully 
competed by the presence of DRP fusion protein but not by 
dystrophin fusion protein.  This  suggests that the affinity- 
purified DRP  antibodies used were specific for DRP and 
capable of recognizing DRP-peptide despite the presence of 
the peptides encoding the carboxyl terminus of dystrophin, 
by immunofluorescence. 
Enrichment of  DRP in Blood Vessels and the 
Choroid Plexus 
Having ensured that the DRP antibodies were specific and 
sensitive enough to distinguish DRP from dystrophin, we 
used these affinity-purified  antibodies to quantitate regional 
differences in the amount of DRP in the (full length) dystro- 
phin null mutant mdx mouse brain. Various regions of adult 
mdx mouse brain were dissected out, protein content quanti- 
tared, and equivalent amounts fractionated by SDS-PAGE, 
electro-transferred and immunoblotted with DRP antibod- 
ies. As shown in Fig. 3, DRP was detected in blood vessels, 
choroid plexus,  cerebral cortex, cerebellum, internal cap- 
Figure 1. Specificity  of affinity  purified DRP antibodies by immu- 
noblotting. Equivalent  amounts of  purified fusion peptides contain- 
ing the carboxyl termini of DRP (DRP fusion: nucleotide position 
690-1,353, Love et al., 1989; homologous to 10,457-11,518 of the 
dystrophin sequence, Koenig et al., 1988) and dystrophin (dll fu- 
sion: nucleotide position 9,786-11,555 of the dystrophin sequence, 
Koenig et al., 1988) were fractionated by SDS-PAGE and electro- 
transferred to nitrocellulose. Immunoblots were processed using 
affinity purified antibodies to the carboxyl termini of DRP. As 
shown above, DRP antibodies recognized minute amounts of DRP 
fusion peptides ('~60 kD) but not fusion peptides expressed by the 
dl 1 clone encoding the carboxyl terminus of dystrophin (predicted 
weight '~100 kD). 
sule, spinal cord, and leptomeninges. The amount of DRP 
in vascular tissue and the highly vascularized choroid plexus 
of the brain was observed to be significantly greater than 
elsewhere. To quantitate the relative amount of DRP in vari- 
ous regions of the brain, the immunoblot was subjected to 
densitometric scanning and the level of DRP was found to 
be approximately threefold greater in cerebral blood vessels 
and choroid plexus compared with other regions of  the brain. 
Similar results were obtained on three independent trials 
using the brains from different mice (data not shown). 
Immunolocalization of  DRP in the mdx Mouse Brain 
Having determined by Western blotting areas of the brain 
that were enriched in DRP, we extended these findings using 
immunofluorescent microscopy. A survey of cross sections 
of brain tissue revealed intense DRP immunolabeling at the 
pia  mater,  choroid plexus,  and  intracerebrai  vasculature, 
Khurana et al. Location of Dystrophin-related Protein in the Brain  359 Figure 2. Specificity  of affinity purified DRP antibodies  by immunofluorescence.  10-#m-thick serial  sections  of mdx mouse brains were 
incubated for I h with (A) DRP antibodies  alone, (8) DILP antibodies  +  I mg dystrophin fusion peptide (DYS-pep: dll fusion: nucleotide 
position 9,786--11,555 of the dystrophin sequence,  Koenig et al.,  1988), (C) DRP antibodies  +  DRP fusion protein (DRP-pep: nuclcotide 
position 690-1,353,  Love et al., 1989; homologous to 10,45%11,518 of the dystrophin sequence,  Kocnig et al.,  1988) and (D) Prcimmune 
scra (PRE). Slides were processed as described in Materials  and Methods and photographed. The immunolabeling pattern was unchanged 
despite the presence of DYS-pop. The immunolabeling was competed with DRP-pep itself as evidenced by precipitated complexes,  consis- 
tent with previous results obtained while affinity purifying the DRP antibodies  against the DRP-pep (Khurana et al.,  1990). Bar, 50 #tm. 
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of the mdx mouse brain.  Various regions of the brain were dis- 
sected, solubilized, and proteins quantified  as described in Materi- 
als and Methods. Equivalent amounts were fractionated by electro- 
phoresis  and  immunoblotted  with  DRP  antibodies. Different 
regions analyzed were (1)  cerebral  blood vessels, (2)  ehoroid 
plexus, (3) cerebral cortex (4) cerebellum, (5) internal capsule, (6) 
spinal cord (cervical level), (7) skeletal muscle (control), and (8) 
leptomeninges (separate blot, same quantity of total protein). As 
demonstrated the DRP content (marked DRP; 427 kD) of cerebral 
blood vessels and choroid plexus is greater than other regions of 
the brain. The experiment was repeated three times and one repre- 
sentative blot subjected to densitometric analysis. DRP content of 
vessels and choroid was •3  times greater than other regions. 
however,  only minimal DRP immunolabeling was detected 
in neuronal or glial elements of  brain parenchyma (Fig. 4 A). 
The pia mater was immunolabeled, both at the surface of  the 
brain and within infolding  of  the sulci. Intracerebral vascular 
structures  such  as  veins,  arteries,  smaller arterioles  and 
capillaries were immtmolabeled  uniformly with the antibody 
(Fig. 4 B). The choroid plexus was found to label intensely, 
as were the specialized vessels forming the plexus, vessels 
associated with the ependyma and the ependyma itself (Fig. 
4 C). The immunolabeling associated with the pial surfaces 
on the exterior surface of the brain was seen to follow invagi- 
nations of vasculature into the brain parenchyma along the 
anatomical space of Virchow-Robin (Fig. 4 D), however,  it 
was not possible to distinguish, at the level of light micros- 
copy if the leptomeningial immunolabeling was at the outer 
pial layer or associated with the inner, closely associated glia 
limitans.  The  identity of immunolabeled  structures  was 
verified by analyzing their characteristic morphology with 
phase-contrast microscopy. In some cases serial sections 
were also stained with haematoxylin  and eosin (H&E), crys- 
tal violet or labeled with antibodies against the endothelial 
marker, yon Willebrand's factor to further validate the nature 
of identified structures. Additionally, similar immunolabel- 
ing results were obtained using normal B10 mice (data not 
shown). Preimmune sera from the same rabbit was used as 
a negative control to exclude nonspecific cross-reactivity in 
all experiments for both immunolabeling (Fig. 4 E), and im- 
munoblots of dissected mdr cerebral blood vessels (data not 
shown). 
DRP  Immunolabeling Across Species 
After  definition of  DRP  distribution  in  the  mammalian 
brain by immunofiuorescence we addressed the question of 
whether the distribution of DRP in the brain was conserved 
across species, since such conservation is often indicative of 
significant physiological function.  Previously it has  been 
demonstrated that the gene encoding DRP, the protein and 
the subcellular distribution  of  DRP in the muscle is conserved 
across species (Love et al., 1989; Khurana et al., 1990; Car- 
taud et al., 1992). We therefore analyzed by immunofluores- 
cent microscopy, the distribution of DRP in cryosections of 
brain from Raja erinacea, an elasmobranch fish that is evo- 
lutionarily quite divergent from mammals. Significant, uni- 
form immunolabeling was visualized at intracerebral vas- 
culature with DRP  antibodies (Fig.  5  A).  Since the Raja 
erinacea intracerebral vessels possess a  fenestrated endo- 
thelial lining rather than a relatively impermeable one, an 
ideal comparison would entail using the few rare regions of 
the mammalian brain parenchyma proper that have fenes- 
trated endothelium as well. We therefore analyzed the area 
postrema from the mdx mouse brain (an area with fenestrated 
endothelium) for this comparison, and found similar patterns 
of immunolabeling with DRP antibodies as well (Fig. 5 B). 
The overall pattern of DRP immunolabeling in both regions 
was similar to that seen in other regions of the mdx mouse 
brain (Fig. 4). 
DRP Is Expressed in Tissue Culture 
While  DRP  immunolabeling was  consistently associated 
with intracerebral capillaries, owing to the limited resolution 
by immunofluorescence microscopy, it is possible that DRP 
is distributed with components of the brain that lie in close 
proximity to the capillaries rather than the capillaries them- 
selves. To address the possibility of immunolabeling either 
perivascular glia or neurons, these two major components of 
the brain were cultured in relative isolation from each other 
and analyzed for DRP content. Thus, we generated primary 
cultures  of  neurons  and  glia  from  mdx  mouse  brains, 
quantified proteins and analyzed equal amounts by immuno- 
blotting with DRP antibodies. As shown in Fig. 6, both neu- 
rons and glial cultures expressed DRP however, glial cultures 
expressed significantly greater amounts of DRP than neu- 
ronal cultures. The lower expression of DRP in neurons is 
consistent with the minimal immunolabeling of identified 
neurons observed by immunofluorescence. The high levels 
of DRP expression in glial cultures may reflect the increased 
expression of  DRP in the pool of  perivascular glia, consistent 
with the possibility that perivascular regions of the brain 
were immunolabeled by DRP antibodies (Fig. 4). 
DRP  Is Selectively  Expressed at the Foot Processes of 
Perivascular Astrocytes 
Both immunofluorescent microscopy and tissue culture ex- 
periments using DRP antibodies coupled with the anatomi- 
cal structure of the intracerebral vasculature suggest the pos- 
sibility  that  perivascular  glia  are  enriched  in  DRP.  To 
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tissue from Raja erinacea (A) and mdx mouse brain (B) were labeled with DRP antibodies. (A) Vascular labeling was similar to that seen 
in murine brain (compare with Fig. 4).  (B) Transverse section at the level of the area postrema shows immunolabeled blood vessels, the 
overall pattern  of both panels is similar to that seen in the rest of the mdx mouse brain.  Bar, 50 #m. 
address this issue directly and define the subceUular localiza- 
tion of DRP we used the higher resolution offered by im- 
munogold EM to examine the distribution  of DRP in mdx 
brain sections. DRP was seen to selectively label the end-feet 
or  foot  processes  of  astrocytes  closely  apposed  to  in- 
tracerebral blood vessels (Fig. 7). Astrocytes were identified 
by their characteristic morphology and presence of glial fila- 
ments within the foot process (Fig. 7). The immunolabeling 
was seen to be maximal at the inner plasma face of astro- 
cytes, regions forming the glio-vascular interface. Since the 
perivascular glia completely surround capillaries, this loca- 
tion of DRP is consistent with the uniform perivascular im- 
munolabeling seen by fluorescent microscopy using DRP an- 
tibodies  (Fig.  4).  No  immunolabeling  was  noted  at  the 
luminal aspect of basal lamina surrounding the endothelial 
cells. Sections labeled with either no primary or control anti- 
bodies were negative (data not shown). 
Discussion 
Using complementary immunoassays, cell biological,  and 
microscopic techniques, we have determined the distribution 
of the chromosome 6 encoded DRP in the mdx mouse brain. 
DRP is expressed in neuronal, glial, and vascular cells of the 
brain and is enriched in neuroglial cells.  DRP is localized 
at the end-feet of astrocytes closely apposed to capillaries, 
pia  mater,  intracerebral  vasculature,  the  ependyma,  and 
choroid plexus.  Since proteins structurally similar to DRP 
are known to exist (e.g., dystrophin), it is of crucial impor- 
tance  to  exclude their  inadvertent  visualization in  studies 
such as this. To avoid anomalous cross-reaction with dystro- 
phin we used the mdx mouse. This mouse strain harbors a 
point  mutation  in  the  dystrophin  gene that  precludes  the 
translation of dystrophin, hence analysis of brain tissue from 
this mouse excludes the possibility of inadvertent visualiza- 
tion of full length dystrophin (Sicinski et al.  1989).  Impor- 
tantly,  while no full length dystrophin is made in the mdx 
mouse,  an alternative,  smaller transcript encoding dystro- 
phin's carboxyl terminus alone has recently been suggested 
to exist and to be expressed in nonmuscular tissues of this 
mouse (Bar et al.,  1990;  Rapaport et al.,  1992).  However, 
the antibodies used here only recognize the full length DRP 
and do not detect the 71-kD,  smaller, alternative DMD gene 
product in the brain of mdx mice (Lederfein et al.,  1992) 
(Fig.  3).  Furthermore,  peptide  competition  experiments 
clearly demonstrate that DRP antibodies can recognize DRP 
even in the presence of an excess of dystrophin carboxyl- 
terminal  epitopes,  both on  immunoblotting  and  immuno- 
histochemistry (Figs. 1 and 2). The use of specific and sensi- 
tive DRP antibodies,  correlation of immunohistochemical 
and  immunoblot  results  and  tissue  culture  experiments 
strongly suggest that we are describing the distribution  of 
DRP itself rather than dystrophin or its known isoforms at 
the aforementioned sites, although this possibility cannot be 
formally ruled out in the absence of a null mutant for DRP. 
In mammals the term "blood-brain barrier" refers to the 
endothelial cell-based permeability barrier that prevents the 
Figure 4. Immunolocalization of DRP in the mdx mouse brain. 7-10-#m cryosections of  mdx mouse brain were labeled with DRP antibodies 
and visualized by indirect immunofluorescence.  (A) DRP antibodies label the chomid plexus and pia mater (open arrows). A muscular 
artery is also labeled (closed arrow). All calibers of cerebral vessels were labeled and visualized in different orientations (i.e., lengthwise, 
tangentially, and end-on) within the substance of  both the cerebral (Crm) and cerebellar (Cbm) hemispheres. (B) Irnmunolabeling of arteri- 
oles (closed arrows) and invaginations of the pia mater around the vessels (open arrows). (C) Intense immunolabeling is seen in the choroid 
plexus (open arrows) and ependyma lining the ventricular cavity (closed arrows). (D) The immunolabeling associated with blood vessels 
is seen to be colocalized with investments of the pia mater from the surface of the cerebellum. E demonstrates  a lack of immunolabeling 
with preimmune antisera  from the same rabbit.  (C)  100 #m; (A, B, and D) 50 #m. 
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tissue  culture.  Primary  cul- 
tures of neurons and glia were 
made from mdx mouse brains. 
The cells were harvested, pro- 
teins quantified, and equivalent 
amounts electrophoresed and 
immunoblotted with DRP an- 
tibodies. DRP was detected in 
(1) mdx cerebral vessels (con- 
trol), (2) mdx cultured neurons, (3) mdx cultured gila, and (4) mdx 
skeletal muscle (control). Note: background staining for various 
lanes with these DRP antibodies was dependent on the complexity 
of tissue type rather than loading differences (compare lanes 1 and 
4;  see Khurana et ai.,  1990). As  shown, DRP expression was 
greater in cultured glia as compared with neurons. 
entry of many blood-borne molecules into the brain paren- 
chyma, thus helping maintain the milieu interieur necessary 
for neuronal function. Additionally, vascular pericytes and 
perivascular neuroglia, while not forming the actual barrier, 
have been ascribed a supportive role in the maintenance of 
blood-brain barrier integrity (Peters et al.,  1991; Risau and 
Wolburg, 1990; Cserr and Bundgaard, 1984). Indeed, cocul- 
tured astrocytes are considered crucial for the induction of 
polarity and barrier properties among endothelial cells in 
murine models (Beck et al.,  1984; Janzer and Raft,  1987; 
Tao-Cheng et al.,  1987).  Interestingly,  in  submammalian 
vertebrates (Elasmobranchs, e.g., Torpedo fish, skates and 
sharks) and invertebrates the endothelial cell layer is "leaky" 
and the barrier function is carried out exclusively  by the end- 
feet of perivascular astrocytes (Bundgaard and Cserr, 1981). 
Such comparative studies have led to the suggestion that the 
mammalian  (endothelial)  blood-brain  barrier  may  have 
evolved from an ancient one based solely on glial end-feet 
ensheathing blood vessels as they coursed through the primi- 
tive brain (Cserr and Bundgaard, 1984). Our demonstration 
that DRP is located within these perivascular astrocytes and 
conservation of its distribution over 400 million years of evo- 
lution strengthens the suggestion that perivascular astrocytes 
and proteins present in them (such as DRP) may play a role 
in maintaining the cellular specializations associated with 
the blood-brain barrier, perhaps by influencing the spatial 
regulation of intrarnembranous proteins such as ion channels 
or the orthogonal array of  particles (OAPs) that cluster in this 
region of the astrocyte (Risau and Wolburg,  1990).  Other 
members of the spectrin superfamily of cytoskeletal proteins 
have  previously been  demonstrated  to  interact  with  and 
stabilize integral membrane proteins, thus helping to form 
and maintain regional cellular specializations (Srinivasan et 
al.,  1988; Coleman et al.,  1989; Bennet 1990). 
Ohlendieck and coauthors drew an analogy between the 
localization of DRP and certain isoforms of laminin in the 
adult skeletal muscle (Ohlendieck et al.,  1991).  The lami- 
nins are constituents of the basal  lamina which  surround 
mammalian muscle and are known to be particularly well 
Figure 7. Immunoelectron mi- 
croscopy of DRP at the blood- 
brain interface. Ultrathin cryo- 
sections of mdx mouse brain 
were incubated with DRP anti- 
bodies and distribution of  DRP 
revealed by 5-nm goat  anti- 
rabbit  gold  conjugates.  The 
figure demonstrates the ultra- 
structure  of the  blood-brain 
barrier. An astrocytic foot pro- 
cess (Ast) is seen to be closely 
apposed  to  an  intracerebral 
capillary. Glial filaments (gf) 
present in the astrocytic foot 
process axe marked. '~lO-fold 
more  gold  particles  (arrow- 
heads) are seen to be distrib- 
uted within astrocytic end-feet 
at the glio-vascular interface, 
than  at  the  endothelial cells 
(End) or lumen of intracere- 
bral capillaries. Bar, 0.2 tzm. 
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sels, and neuromuscular and myotendinous junctions of the 
muscle  (Sanes,  1986;  Sanes  et  al.,  1990).  The  overall 
similarity of distribution of laminin(s) with DRP and dystro- 
phin in the skeletal muscle is quite striking (Sanes and Hall, 
1979; Sanes et al., 1990; Byers et al., 1991; Khurana et al., 
1991;  Man  et al.,  1991;  Ohlendieck et al.,  1991).  In the 
brain,  the basal lamina and laminin are known to be well 
defined  at  the  distinct  locales  of  the  ependymal  lining, 
choroid plexus,  glia limitans,  and the blood-brain  barrier 
(Risau and Wolburg,  1990; Peters et al.,  1991; Hagg et al., 
1989; Chiu et al., 1991).  We find it noteworthy that both the 
laminin(s) and DRP are similarly distributed in the brain as 
well. However, since DRP immunolabeling is wholly intra- 
cellular and laminin isoforms are distributed extracellularly, 
our study suggests that their interaction, if any, is likely to 
be indirect as has been demonstrated in case of dystrophin 
(Ibraghimov-Beskrovnaya  et al.,  1992). 
In conclusion, we have used a variety of techniques to de- 
scribe the distribution of DRP in the mdx mouse brain.  Con- 
sistent with predictions based on cross-reactivity of dystro- 
phin antisera in mdx mice (Ishiura et al., 1990), we detected 
DRP in all regions of the brain tested including the pia mater, 
choroid plexus, cerebral vasculature,  and spinal cord, a dis- 
tribution which is quite different from that described for dys- 
trophin  (Miike et al., 1989; Lidov et al., 1990).  The distri- 
bution of DRP in the brain was conserved over a significant 
period of evolution, from elasmobranch to mammals, sug- 
gesting that DRP plays an important physiological role. DRP 
was located by immunoelectron microscopy to the end-feet 
of perivascular astrocytes,  thus its function is likely to be 
related to the maintenance of blood-brain barrier integrity. 
In view of the possible structural role(s) for DRP, we believe 
that further cell biological and tissue culture experiments are 
needed to address the issue of possible interactive/inductive 
properties of DRP and other proteins located at the blood- 
brain barrier. 
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